RESUMO
There is current interest in harnessing the combined anticancer and immunological effect of nanoparticles (NPs) and RNA. Here, we evaluate the bioactivity of poly I:C (pIC) RNA, bound to anticancer zinc oxide NP (ZnO-NP) against melanoma. Direct RNA association to unfunctionalized ZnO-NP is shown by observing change in size, zeta potential, and absorption/fluorescence spectra upon complexation. RNA corona was visualized by transmission electron microscopy (TEM) for the first time. Binding constant (Kb = 1.6-2.8 g-1 L) was determined by modified Stern-Volmer, absorption, and biological surface activity index analysis. The pIC-ZnO-NP complex increased cell death for both human (A375) and mouse (B16F10) cell lines and suppressed tumor cell growth in BALB/C-B16F10 mouse melanoma model. Ex vivo tumor analysis indicated significant molecular activity such as changes in the level of phosphoproteins JNK, Akt, and inflammation markers IL-6 and IFN-γ. High throughput proteomics analysis revealed zinc oxide and poly I:C-specific and combinational patterns that suggested possible utility as an anticancer and immunotherapeutic strategy against melanoma.
Assuntos
Antineoplásicos/farmacologia , Melanoma Experimental/tratamento farmacológico , Nanopartículas/administração & dosagem , Poli I-C/farmacologia , RNA/farmacologia , Óxido de Zinco/farmacologia , Animais , Biomarcadores Tumorais/metabolismo , Morte Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Humanos , Interferon gama/metabolismo , Interleucina-6/metabolismo , MAP Quinase Quinase 4/metabolismo , Melanoma Experimental/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Proto-Oncogênicas c-akt/metabolismoRESUMO
Biosynthesis of gold nanoparticles (AuNPs) for antimicrobial and chemotherapeutic applications is a well-established process in microbial hosts such as bacterial, fungi, and plants. However, reports on AuNPs biosynthesis in mammalian cells are scarce. In this study, bovine aortic endothelial cells (BAECs) and bovine aortic smooth muscle cells (BASMCs) were examined for their ability to synthesize AuNPs in vitro. Cell culture conditions such as buffer selection, serum concentration, and HAuCl4 concentration were optimized before the biosynthesized AuNPs were characterized through visible spectrometry, transmission electron microscopy, X-ray diffraction, and Fourier transform infrared (FTIR) spectroscopy. BAECs and BASMC produced small, spherical AuNPs that are semi-crystalline with a similar diameter (23 ± 2 nm and 23 ± 4 nm). Hydrogen peroxide pretreatment increased AuNPs synthesis, suggesting that antioxidant enzymes may reduce Au3+ ions as seen in microbial cells. However, buthionine sulfoximine inhibition of glutathione synthesis, a key regulator of oxidative stress, failed to affect AuNPs generation. Taken together, these results show that under the right synthesis conditions, non-tumor cell lines can produce detectable concentrations of AuNPs in vitro.
RESUMO
Aberrant splicing and protein interaction of Ras binding domain (RBD) are associated with melanoma drug resistance. Here, cobalt or nickel doped zinc oxide (ZnO) physiometacomposite (PMC) materials bind to RNA and peptide shown by Ninhydrin staining, UV-vis, Fourier transform infrared, and circular dichroism spectroscopy. PMCs deliver splice switching oligomer (SSO) into melanoma cells or 3-D tumor spheroids shown by flow cytometry, fluorescence microscopy, and bioluminescence. Stability in serum, liver, or tumor homogenate up to 48 h and B16F10 melanoma inhibition ≥98-99% is shown. These data suggest preclinical potential of PMC for delivery of SSO, RBD, or other nucleic acid therapeutic and anticancer peptides.
RESUMO
INTRODUCTION: Biomedical applications of nanoparticles (NPs) as enzyme inhibitors have recently come to light. Oxides of metals native to the physiological environment (eg, Fe, Zn, Mg, etc.) are of particular interest-especially the functional consequences of their enzyme interaction. MATERIALS AND METHODS: Here, Fe2O3, zinc oxide (ZnO), magnesium oxide (MgO) and nickel oxide (NiO) NPs are compared to copper (Cu) and boron carbide (B4C) NPs. The functional impact of NP interaction to the model enzyme luciferase is determined by 2-dimensional fluorescence difference spectroscopy (2-D FDS) and 2-dimensional photoluminescence difference spectroscopy (2-D PLDS). By 2-D FDS analysis, the change in maximal intensity and in 2-D FDS area under the curve (AUC) is in the order Cu~B4C>ZnO>NiO>>Fe2O3>MgO. The induced changes in protein conformation are confirmed by tryptic digests and gel electrophoresis. RESULTS: Analysis of possible trypsin cleavage sites suggest that cleavage mostly occurs in the range of residues 112-155 and 372-439, giving a major 45 kDa band. By 2-D PLDS, it is found that B4C NPs completely ablate bioluminescence, while Cu and Fe2O3 NPs yield a unique bimodal negative decay rate, -7.67×103 and -3.50×101 relative light units respectively. Cu NPs, in particular, give a remarkable 271% change in enzyme activity. Molecular dynamics simulations in water predicted that the surfaces of metal oxide NPs become capped with metal hydroxide groups under physiological conditions, while the surface of B4C becomes populated with boronic acid or borinic acid groups. These predictions are supported by the experimentally determined zeta potential. Thin layer chromatography patterns further support this conception of the NP surfaces, where stabilizing interactions were in the order ionic>polar>non-polar for the series tested. CONCLUSION: Overall the results suggest that B4C and Cu NP functional dynamics on enzyme biochemistry are unique and should be examined further for potential ramifications on other model, physiological or disease-relevant enzymes.
Assuntos
Luciferases/metabolismo , Nanopartículas Metálicas/química , Células 3T3 , Animais , Área Sob a Curva , Compostos de Boro/química , Dicroísmo Circular , Cobre/química , Luciferina de Vaga-Lumes/metabolismo , Cinética , Nanopartículas Metálicas/ultraestrutura , Camundongos , Modelos Moleculares , Óxidos/química , Espectrometria de FluorescênciaRESUMO
Despite their large secretome and wide applications in bioprocesses, fungi remain underexplored in metal nanoparticles (MNP) biosynthesis. Previous studies have shown that cell surface proteins of Rhizopus oryzae play a crucial role in biomineralization of Au(III) to produce gold nanoparticles (AuNPs). Therefore, it is hypothesized that purified cell surface protein may produce in vitro AuNPs with narrow size distribution for biomedical and biocatalytic applications. However, different protein extraction methods might affect protein stability and the AuNP biosynthesis process. Herein, we have explored the extraction of cell surface proteins from R. oryzae using common detergents and reducing agent (sodium dodecyl sulfate (SDS) Triton X-100, and 1,4-dithiothreitol (DTT)) and their effect on the size and shape of the biosynthetic AuNPs. The surface proteins extracted with reducing agent (DTT) and non-ionic detergent (Triton X-100) produce spherical AuNPs with a mean particle size of 16±7nm, and 19±4nm, respectively, while the AuNPs produced by the surface protein extracted by ionic detergent (SDS) are flower-like AuNPs with broader size distribution of 43±19nm. This synthetic approach does not require use of any harsh chemicals, multistep preparation and separation process, favouring environmental sustainability. The biosynthetic AuNPs thus formed, are stable in different physiological buffers and hemocompatible, making them suitable for biomedical applications.
Assuntos
Proteínas Fúngicas/metabolismo , Ouro/química , Nanopartículas Metálicas/química , Biotecnologia , Química Verde , Hemólise , Humanos , Técnicas In Vitro , Teste de Materiais , Proteínas de Membrana/metabolismo , Nanopartículas Metálicas/ultraestrutura , Microscopia Eletrônica de Transmissão , Nanotecnologia , Oxirredução , Rhizopus/metabolismoRESUMO
Gold nanoparticles (AuNPs) are a widespread research tool because of their oxidation resistance, biocompatibility and stability. Chemical methods for AuNP synthesis often produce toxic residues that raise environmental concern. On the other hand, the biological synthesis of AuNPs in viable microorganisms and their cell-free extracts is an environmentally friendly and low-cost process. In general, fungi tolerate higher metal concentrations than bacteria and secrete abundant extracellular redox proteins to reduce soluble metal ions to their insoluble form and eventually to nanocrystals. Fungi harbour untapped biological diversity and may provide novel metal reductases for metal detoxification and bioreduction. A thorough understanding of the biosynthetic mechanism of AuNPs in fungi is needed to reduce the time of biosynthesis and to scale up the AuNP production process. In this review, we describe the known mechanisms for AuNP biosynthesis in viable fungi and fungal protein extracts and discuss the most suitable bioreactors for industrial AuNP biosynthesis.
Assuntos
Biotecnologia/métodos , Fungos/metabolismo , Ouro/metabolismo , Nanopartículas/metabolismo , Reatores BiológicosRESUMO
ZnO nanostructures (ZnO-NSs) of different morphologies are synthesized with the amino acids L-alanine, L-threonine, and L-glutamine as capping agents. X-ray diffraction (XRD) shows the formation of a crystalline wurtzite phase of ZnO-NSs. The surface modification of ZnO-NSs due to the capping agents is confirmed using Fourier transform infrared (FTIR) spectroscopy. Photoluminescence spectroscopy reveals that the concentration of surface defects correlates positively with the number of polar facets in ZnO-NSs. The antimicrobial activity of the ZnO-NSs has been tested against Escherichia coli and the common pathogens Staphylococcus aureus, Klebsiella pneumoniae, and Bacillus subtilis. Culture-based methods in rich medium show up to 90% growth inhibition, depending on the ZnO-NSs. Flow cytometry analyses indicate that the reactive oxygen species (ROS) generated by ZnO-NSs contribute mostly to the antibacterial activity. Control experiments in minimal medium show that amino acids and other reducing agents in Luria-Bertani (LB) medium quench ROS, thereby decreasing the antimicrobial activity of the ZnO-NSs.
Assuntos
Aminoácidos/química , Anti-Infecciosos/farmacologia , Nanoestruturas/química , Óxido de Zinco/síntese química , Óxido de Zinco/farmacologia , Ágar , Bactérias/efeitos dos fármacos , Bactérias/crescimento & desenvolvimento , Endocitose/efeitos dos fármacos , Citometria de Fluxo , Fluoresceínas/metabolismo , Íons , Testes de Sensibilidade Microbiana , Nanoestruturas/toxicidade , Nanoestruturas/ultraestrutura , Espécies Reativas de Oxigênio/metabolismo , Óxido de Zinco/toxicidadeRESUMO
Zinc oxide (ZnO) nanostructures of various morphologies were produced in an aqueous system, with pyridine as a shape-directing agent. X-ray diffraction (XRD) and selected-area electron diffraction (SAED) revealed hexagonal wurtzite crystal structure. Variation in surface morphology was analyzed using transmission electron microscopy (TEM). Changes in surface morphology were attributed to the absence of steric stabilization in pyridine during synthesis process. Pyridine concentration affected morphology and optical properties. Fourier transform infrared spectroscopy (FTIR) confirmed the presence/absence of pyridine on the surface of ZnO nanostructures (ZnO-NSs). Optical measurements carried out using UV-visible spectrophotometer (UV-vis) and photoluminescence (PL) indicated the presence of defects. All the samples exhibited two PL peaks, at 350-370 nm and 560-624 nm. Variation in the intensities of PL peaks corresponded to the changes in the surface morphology from nanoparticles to rods and origin of deep-level defect luminescence is attributed to surface recombination. The toxicity of the nanostructures was tested on model Gram-negative and Gram-positive pathogens. Smaller nanorods were most toxic among the nanostructures tested.